Please login to the form below

Not currently logged in
Email:
Password:

Alapis acquires Pharmalex for USD 19.5m

Greek chemical and pharmaceutical company Alapis has acquired 99.7 per cent of pharmaceutical company Pharmalex for EUR 14.3m (USD 19.5m).

Greek chemical and pharmaceutical company Alapis has acquired 99.7 per cent of pharmaceutical company Pharmalex for EUR 14.3m (USD 19.5m).

Greece-headquartered Pharmalex is not operational at the moment but previously ran production and distribution activities in the region.

The company owns production facilities of 7,500 square metres in Pallini in the Attica basin, on a land plot totalling 13,900 square metres.

According to Alapis management, the company will modernise and expand these production facilities to create a research and development laboratory, and will eventually absorb Pharmalex.

The Pharmalex purchase is the latest in a raft of buy ups across central and southern Europe. Alapis has established two companies, one in Serbia and another in Hungary, both of which will specialise in the production and trade of veterinary medicines and foods.

The Serbia-based operation is called Veterin Pharma Doo and has its headquarters in Beograd. The other company, based in Budapest, Hungary, is called Veterin Hungary. Alapis is the sole share holder in both companies.

Alapis already co-operates with Germany-headquartered Bayer on the production of veterinary drugs in Greece, Romania and Bulgaria.

13th August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Redbow Consulting Group

Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...